Canada Human Embryonic Stem Cells Market Size & Outlook
Canada human embryonic stem cells market, 2018-2030 (US$M)
Related Markets
Canada human embryonic stem cells market highlights
- The Canada human embryonic stem cells market generated a revenue of USD 155.8 million in 2023 and is expected to reach USD 300.4 million by 2030.
- The Canada market is expected to grow at a CAGR of 9.8% from 2024 to 2030.
- In terms of segment, regenerative medicine was the largest revenue generating application in 2023.
- Drug Discovery & Development is the most lucrative application segment registering the fastest growth during the forecast period.
Human embryonic stem cells market data book summary
| Market revenue in 2023 | USD 155.8 million |
| Market revenue in 2030 | USD 300.4 million |
| Growth rate | 9.8% (CAGR from 2023 to 2030) |
| Largest segment | Regenerative medicine |
| Fastest growing segment | Drug Discovery & Development |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Regenerative Medicine, Drug Discovery & Development |
| Key market players worldwide | Thermo Fisher Scientific Inc, Sartorius Stedim Biotech SA, Element Solutions Inc, PromoCell GmbH, Lonza Group Ltd, LifeCell International, Gilead Sciences Inc, International Stem Cell Corp |
Other key industry trends
- In terms of revenue, Canada accounted for 10.9% of the global human embryonic stem cells market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. human embryonic stem cells market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 300.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Human Embryonic Stem Cells Market Scope
Human Embryonic Stem Cells Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Canada human embryonic stem cells market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to human embryonic stem cells market will help companies and investors design strategic landscapes.
Regenerative medicine was the largest segment with a revenue share of 90.37% in 2023. Horizon Databook has segmented the Canada human embryonic stem cells market based on regenerative medicine, drug discovery & development covering the revenue growth of each sub-segment from 2018 to 2030.
Canadian Institutes of Health Research (CIHR) is the major federal agency that provides funding for research in healthcare in Canada. Canada is expected to register substantial growth in the coming years owing to the recent changes in guidelines for stem cell research by International Society for Stem Cell Research (ISSCR) which are followed by the country.
Further, the country is bound by Assisted Human Reproduction Act for all the research concerned with assisted human reproduction including the use of hESC for research or other applications. Availability of funds to conduct research, advances in stem cell research, and permissions to conduct research on human-embryo derived stem cells is expected to boost the market growth for the country.
Reasons to subscribe to Canada human embryonic stem cells market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada human embryonic stem cells market databook
-
Our clientele includes a mix of human embryonic stem cells market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada human embryonic stem cells market , including forecasts for subscribers. This country databook contains high-level insights into Canada human embryonic stem cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada human embryonic stem cells market size, by application, 2018-2030 (US$M)
Canada Human Embryonic Stem Cells Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
